Scope’s CRISPR Molecular Diagnostics CE Marked for Antifungal Resistance
October 6, 2026

October 6, 2026
October 5, 2026
October 1, 2026
September 21, 2026
September 10, 2026
A new initiative to connect and empower early-career pathologists across Europe
September 2, 2026
September 1, 2026
August 27, 2026
October 6, 2026
Developed with AmplexDiagnostics, eazySNP brings scopeDx® into human diagnostics Scope Biosciences B.V., a Wageningen University spinoff life sciences...
October 5, 2026
Collaboration combines CellCarta’s global clinical trial testing capabilities with Waters’ standardized flow cytometry platforms and expertise CellCar...
October 1, 2026
The collaboration combines Imagene’s AI-powered assay development and biomarker prediction capabilities with CellCarta’s global companion diagnostics ...

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225